Related references
Note: Only part of the references are listed.Delivering cellular and gene therapies to patients: solutions for realizing the potential of the next generation of medicine
Kris Elverum et al.
GENE THERAPY (2020)
Regulators' Advice Can Make a Difference: European Medicines Agency Approval of Zynteglo for Beta Thalassemia
Martina Schuessler-Lenz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Helena Costa Verdera et al.
MOLECULAR THERAPY (2020)
Expanding the editable genome and CRISPR-Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking
Xiaoyu Chen et al.
NUCLEIC ACIDS RESEARCH (2020)
Tandem Paired Nicking Promotes Precise Genome Editing with Scarce Interference by p53
Toshinori Hyodo et al.
CELL REPORTS (2020)
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
K. John Pasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
Christopher E. Nelson et al.
NATURE MEDICINE (2019)
A Phase I-II Study Using Rexin-G Tumor-Targeted Retrovector Encoding a Dominant-Negative Cyclin G1 Inhibitor for Advanced Pancreatic Cancer
Sant P. Chawla et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1
Ewelina Mamcarz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A next-generation sequencing method for gene doping detection that distinguishes low levels of plasmid DNA against a background of genomic DNA
Eddy N. de Boer et al.
GENE THERAPY (2019)
State-of-the-Art 2019 on Gene Therapy for Phenylketonuria
Hiu Man Grisch-Chan et al.
HUMAN GENE THERAPY (2019)
Gene therapy for glycogen storage diseases
Priya S. Kishnani et al.
HUMAN MOLECULAR GENETICS (2019)
Advances and challenges for hemophilia gene therapy
Paul Batty et al.
HUMAN MOLECULAR GENETICS (2019)
Progress and challenges in development of new therapies for urea cycle disorders
Leandro R. Soria et al.
HUMAN MOLECULAR GENETICS (2019)
Current Status on Clinical Development of Adeno-Associated Virus-Mediated Liver-Directed Gene Therapy for Inborn Errors of Metabolism
Virginia Maria Ginocchio et al.
HUMAN GENE THERAPY (2019)
CRISPR DNA base editors with reduced RNA off-target and self-editing activities
Julian Grunewald et al.
NATURE BIOTECHNOLOGY (2019)
Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders
Alireza Shahryari et al.
FRONTIERS IN GENETICS (2019)
Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors
Anita Kruzik et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone et al.
NATURE (2019)
High levels of AAV vector integration into CRISPR-induced DNA breaks
Killian S. Hanlon et al.
NATURE COMMUNICATIONS (2019)
State-of-the-art human adenovirus vectorology for therapeutic approaches
Jian Gao et al.
FEBS LETTERS (2019)
Gene therapy for lysosomal storage diseases and peroxisomal diseases
Toya Ohashi
JOURNAL OF HUMAN GENETICS (2019)
Clinical applications of CRISPR-based genome editing and diagnostics
Dana V. Foss et al.
TRANSFUSION (2019)
A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism
Marcus Davidsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Immunology of Adenoviral Vectors in Cancer Therapy
Amanda Rosewell Shaw et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Precise and efficient nucleotide substitution near genomic nick via noncanonical homology-directed repair
Kazuhiro Nakajima et al.
GENOME RESEARCH (2018)
Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAs
Daniel E. Ryan et al.
NUCLEIC ACIDS RESEARCH (2018)
Implementing a Program of Talimogene laherparepvec
Frances Collichio et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Oncorine, the World First Oncolytic Virus Medicine and its Update in China
Min Liang
CURRENT CANCER DRUG TARGETS (2018)
A decade of marketing approval of gene and cell-based therapies in the United States, European Union and Japan: An evaluation of regulatory decision-making
D. G. M. Coppens et al.
CYTOTHERAPY (2018)
The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
Wei-Wei Zhang et al.
HUMAN GENE THERAPY (2018)
The ethics of clinical applications of germline genome modification: a systematic review of reasons
Ivy van Dijke et al.
HUMAN REPRODUCTION (2018)
Gene therapy clinical trials worldwide to 2017: An update
Samantha L. Ginn et al.
JOURNAL OF GENE MEDICINE (2018)
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
Dan H. Barouch et al.
LANCET (2018)
Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety
Maria Pia Cicalese et al.
MOLECULAR THERAPY (2018)
Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction
Luke W. Koblan et al.
NATURE BIOTECHNOLOGY (2018)
Optimized base editors enable efficient editing in cells, organoids and mice
Maria Paz Zafra et al.
NATURE BIOTECHNOLOGY (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
A. A. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature
Maddalena Migliavacca et al.
FRONTIERS IN IMMUNOLOGY (2018)
Platelet-Targeted Gene Therapy for Hemophilia
Qizhen Shi
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
Pasqualina Colella et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Base editing: precision chemistry on the genome and transcriptome of living cells
Holly A. Rees et al.
NATURE REVIEWS GENETICS (2018)
Shock greets claim of CRISPR-edited babies
Dennis Normile
SCIENCE (2018)
DNA, RNA, and Protein Tools for Editing the Genetic Information in Human Cells
Xiaoyu Chen et al.
ISCIENCE (2018)
A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks
Georgi Shukarev et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects
Julien Baruteau et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Stephen Russell et al.
LANCET (2017)
Regeneration of the entire human epidermis using transgenic stem cells
Tobias Hirsch et al.
NATURE (2017)
Enhanced proofreading governs CRISPR-Cas9 targeting accuracy
Janice S. Chen et al.
NATURE (2017)
Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage
Nicole M. Gaudelli et al.
NATURE (2017)
Non-homologous DNA end joining and alternative pathways to double-strand break repair
Howard H. Y. Chang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
J. R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
L. A. George et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
AAV5-Factor VIII Gene Transfer in Severe Hemophilia A
Savita Rangarajan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
Waseem Qasim et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models
Nicola Brunetti-Pierri et al.
VIRUS GENES (2017)
In trans paired nicking triggers seamless genome editing without double-stranded DNA cutting
Xiaoyu Chen et al.
NATURE COMMUNICATIONS (2017)
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Michael F. Naso et al.
BIODRUGS (2017)
Rationally engineered Cas9 nucleases with improved specificity
Ian M. Slaymaker et al.
SCIENCE (2016)
Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis
Daniel Gaudet et al.
HUMAN GENE THERAPY (2016)
Neutralizing Antibodies Against Adeno-Associated Viral Capsids in Patients with mut Methylmalonic Acidemia
Elizabeth A. Harrington et al.
HUMAN GENE THERAPY (2016)
Origins of Programmable Nucleases for Genome Engineering
Srinivasan Chandrasegaran et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs
Julio Alonso-Padilla et al.
MOLECULAR THERAPY (2016)
Engineered Viruses as Genome Editing Devices
Xiaoyu Chen et al.
MOLECULAR THERAPY (2016)
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Alexis C. Komor et al.
NATURE (2016)
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P. Kleinstiver et al.
NATURE (2016)
Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency
Suk See De Ravin et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
In vivo tissue-tropism of adeno-associated viral vectors
Arun Srivastava
CURRENT OPINION IN VIROLOGY (2016)
Manufacturing of recombinant adeno-associated viral vectors for clinical trials
Nathalie Clement et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Gene therapy for primary immunodeficiencies
A. Fischer et al.
CLINICAL GENETICS (2015)
CAV-2-why a canine virus is a neurobiologist's best friend
Felix Junyent et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Gene Therapy for Inherited Diseases of Liver Metabolism
Pasquale Piccolo et al.
HUMAN GENE THERAPY (2015)
Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy
Randy J. Chandler et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee
J. J. Cherian et al.
OSTEOARTHRITIS AND CARTILAGE (2015)
Genome editing at the crossroads of delivery, specificity, and fidelity
Ignazio Maggio et al.
TRENDS IN BIOTECHNOLOGY (2015)
Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases
Richard L. Frock et al.
NATURE BIOTECHNOLOGY (2015)
Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency
Ying Dang et al.
GENOME BIOLOGY (2015)
Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease
Carolin Anders et al.
NATURE (2014)
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2014)
Engineering adeno-associated viruses for clinical gene therapy
Melissa A. Kotterman et al.
NATURE REVIEWS GENETICS (2014)
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Pablo Tebas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
S. Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
A. C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems
Ines Fonfara et al.
NUCLEIC ACIDS RESEARCH (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
Gene Therapy for Wiskott-Aldrich Syndrome-Long-Term Efficacy and Genotoxicity
Christian Joerg Braun et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Correction of Hyperbilirubinemia in Gunn Rats by Surgical Delivery of Low Doses of Helper-Dependent Adenoviral Vectors
Francoise Schmitt et al.
HUMAN GENE THERAPY METHODS (2014)
Robust ZFN-mediated genome editing in adult hemophilic mice
Xavier M. Anguela et al.
BLOOD (2013)
Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
F. Ann Ran et al.
CELL (2013)
Transgene Expression up to 7 Years in Nonhuman Primates Following Hepatic Transduction with Helper-Dependent Adenoviral Vectors
Nicola Brunetti-Pierri et al.
HUMAN GENE THERAPY (2013)
CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
Prashant Mali et al.
NATURE BIOTECHNOLOGY (2013)
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Seung Woo Cho et al.
NATURE BIOTECHNOLOGY (2013)
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2013)
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity
Thomas J. Cradick et al.
NUCLEIC ACIDS RESEARCH (2013)
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
Alessandro Aiuti et al.
SCIENCE (2013)
Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
Alessandra Biffi et al.
SCIENCE (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Adenovirus DNA Replication
Rob C. Hoeben et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation
Luca Vago et al.
BLOOD (2012)
Reversal of Metabolic and Neurological Symptoms of Phenylketonuric Mice Treated with a PAH Containing Helper-Dependent Adenoviral Vector
Monica Cerreto et al.
CURRENT GENE THERAPY (2012)
TALE nucleases: tailored genome engineering made easy
Claudio Mussolino et al.
CURRENT OPINION IN BIOTECHNOLOGY (2012)
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
Giedrius Gasiunas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Zinc-Finger Nucleases for Somatic Gene Therapy: The Next Frontier
Shamim H. Rahman et al.
HUMAN GENE THERAPY (2011)
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
Elitza Deltcheva et al.
NATURE (2011)
In vivo genome editing restores haemostasis in a mouse model of haemophilia
Hojun Li et al.
NATURE (2011)
A TALE nuclease architecture for efficient genome editing
Jeffrey C. Miller et al.
NATURE BIOTECHNOLOGY (2011)
The Discovery of Zinc Fingers and Their Applications in Gene Regulation and Genome Manipulation
Aaron Klug
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype
Niek P. van Til et al.
BLOOD (2010)
Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
Michelle Christian et al.
GENETICS (2010)
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
Stefan Stein et al.
NATURE MEDICINE (2010)
Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency
Salima Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency
James M. Wilson
MOLECULAR GENETICS AND METABOLISM (2009)
Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors
Ute Modlich et al.
MOLECULAR THERAPY (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Transcription Factor Binding Sites Are Genetic Determinants of Retroviral Integration in the Human Genome
Barbara Felice et al.
PLOS ONE (2009)
Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
Jens Boch et al.
SCIENCE (2009)
A Simple Cipher Governs DNA Recognition by TAL Effectors
Matthew J. Moscou et al.
SCIENCE (2009)
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Nathalie Cartier et al.
SCIENCE (2009)
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
Steven J. Howe et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency
Susannah I. Thornhill et al.
MOLECULAR THERAPY (2008)
AAV vector integration sites in mouse hepatocellular carcinoma
Anthony Donsante et al.
SCIENCE (2007)
Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia
Dwight D. Koeberl et al.
MOLECULAR THERAPY (2007)
Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies
Qizhen Shi et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Adenovirus:: from foe to friend
MAFV Gonçalves et al.
REVIEWS IN MEDICAL VIROLOGY (2006)
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
MG Ott et al.
NATURE MEDICINE (2006)
A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action
Kira S. Makarova et al.
BIOLOGY DIRECT (2006)
Type III effector proteins from the plant pathogen Xanthomonas and their role in the interaction with the host plant
D Gürlebeck et al.
JOURNAL OF PLANT PHYSIOLOGY (2006)
Helper functions required for wild type and recombinant adeno-associated virus growth
MC Geoffroy et al.
CURRENT GENE THERAPY (2005)
A concise peer into the background, initial thoughts and practices of human gene therapy
MAFV Gonçalves
BIOESSAYS (2005)
Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes
ZY Yan et al.
JOURNAL OF VIROLOGY (2005)
Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector
RWR Dudley et al.
HUMAN GENE THERAPY (2004)
Adeno-associated virus vectors integrate at chromosome breakage sites
DG Miller et al.
NATURE GENETICS (2004)
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina et al.
SCIENCE (2003)
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
SE Raper et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination:: Efficient human cell infection and bypass of preexisting adenovirus immunity
R Vogels et al.
JOURNAL OF VIROLOGY (2003)
AAV serotype 2 vectors preferentially integrate into active genes in mice
H Nakai et al.
NATURE GENETICS (2003)
Transcription start regions in the human genome are favored targets for MLV integration
XL Wu et al.
SCIENCE (2003)
Urea-cycle disorders as a paradigm for inborn errors of hepatocyte metabolism
A Mian et al.
TRENDS IN MOLECULAR MEDICINE (2002)
HIV-1 integration in the human genome favors active genes and local hotspots
ARW Schröder et al.
CELL (2002)
Chromosomal effects of adeno-associated virus vector integration
DG Miller et al.
NATURE GENETICS (2002)
A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine Transcarbamylase deficiency
SE Raper et al.
HUMAN GENE THERAPY (2002)
Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver
ZY Chen et al.
MOLECULAR THERAPY (2001)
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
M Cavazzana-Calvo et al.
SCIENCE (2000)
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
MA Kay et al.
NATURE GENETICS (2000)
Share Paper
